NSE’s own daily publication

Nifty Pharma P/E ratio today

Price to earnings (P/E), price to book (P/B) and dividend yield for the Nifty Pharma, which is currently slightly expensive — the 62nd percentile of 3,579 daily closes since 2012. Close of 11 Sept 2026.

Every NSE index, cheapest first

How the Nifty Pharma’s valuation reads today

Against the market. The Nifty Pharma trades at 2.08× the Nifty 50’s P/E, against a median of 1.67× across 3,579 days they were both priced — a wider premium than usual. A sector can look dear on its own numbers while being cheap against the market, and that gap is usually the more useful of the two.
The range it has actually traded in. Its P/E has been as low as 19.87 (Mar 2020) and as high as 83.32 (Aug 2015). Both ends are real closes, not a model — and the high end of an index P/E is usually an earnings collapse rather than a price melt-up, which is why the bands below are percentiles and not a mean.
Versus a year ago. 41.08 today, up from 32.24 a year ago. The ratio moves on price and on earnings, so a falling P/E can mean the index got cheaper or that its constituents earned more — the Nifty Pharma level itself is what separates the two.

Price to earnings

41.08Slightly expensive

62nd percentile of 3,579 days · median 37.34

Price to book

4.99Fairly valued

49th percentile of 3,579 days · median 5.00

Dividend yield

0.54%Slightly expensive

24th percentile of 3,579 days · median 0.65

Where the Nifty Pharma P/E ratio sits today

Valuation zones for the Nifty Pharma price to earnings
Zone	P/E range	What it has meant
Undervalued	below 30.95	Historically cheap — the zone that has rewarded adding, not waiting.
Fairly valued	30.95 – 37.34	Nothing to act on. Keep SIPs running at their normal size.
Slightly expensiveyou are here	37.34 – 51.46	Above the ten-year middle. Stagger a lump sum rather than timing it.
Expensive	above 51.46	Historically dear — rebalancing to your target allocation is the honest response.

Bands are the 10th and 90th percentiles of 3,579 daily closes, with the median as the middle line — so the cheapest and dearest tenth of this index’s own history bound the outer zones, and one freak print cannot move them. They describe where this index has traded, not where it should — a market can stay expensive for years, and this is not a signal to act on.

All three, since 2012

Each cell is the median of that month’s daily closes — one day’s print can be an earnings-revision artefact, and on a grid this size that day would colour the whole month. Hover a cell for the trading-day count behind it, or the line above it for any day’s close. All three are always shown; the buttons at the top only change which metric the valuation zones describe.

Nifty Pharma P/E ratio, month by month

above +1 SD 48.76median 37.34below −1 SD 30.76

Price to earnings by month, 2012 to 2026, as the median of each month’s daily closes
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2012	·	31.60	47.35	49.82	42.88	40.98	42.60	52.60	53.34	53.08	42.62	44.28
2013	44.62	41.75	32.51	33.95	40.08	41.61	45.47	44.09	44.88	47.07	47.78	48.36
2014	50.27	49.05	45.93	46.91	38.86	39.93	43.89	31.33	32.27	32.29	37.43	35.19
2015	35.31	47.55	52.03	52.77	55.76	51.94	55.25	75.63	74.00	76.86	59.36	58.99
2016	57.47	42.98	42.66	42.27	42.58	41.58	44.92	44.41	44.62	44.00	39.73	38.14
2017	38.70	37.97	37.95	37.09	35.98	34.94	36.46	36.73	44.93	46.88	47.44	44.81
2018	47.41	47.12	46.98	49.36	47.31	51.92	52.84	58.85	51.12	47.46	46.09	48.30
2019	48.88	49.08	51.57	52.98	47.24	38.48	38.54	32.04	32.45	29.22	29.48	25.47
2020	26.07	25.71	21.49	28.34	29.04	30.86	31.00	33.26	32.88	33.84	35.11	37.20
2021	38.68	35.55	33.49	34.80	36.59	35.97	36.84	30.28	30.61	31.09	31.91	31.47
2022	32.41	31.38	32.56	33.32	31.87	37.00	38.16	37.28	37.16	36.70	33.90	33.27
2023	32.89	31.46	30.88	32.77	31.58	28.76	30.61	32.32	32.29	31.89	31.83	32.70
2024	35.01	36.17	35.93	36.57	35.48	35.38	37.49	37.95	38.60	38.58	35.12	35.45
2025	34.90	32.45	31.29	32.01	31.80	31.00	32.15	31.80	32.14	34.22	33.80	33.60
2026	33.17	33.69	33.93	33.61	37.82	37.12	39.74	41.29	41.30	·	·	·

cheapestdearest· shaded by rank among all 176 months, not by absolute value — the series is skewed enough that a linear ramp would flatten a decade into one colour

Nifty Pharma P/B ratio, month by month

above +1 SD 6.37median 5.00below −1 SD 3.91

Price to book by month, 2012 to 2026, as the median of each month’s daily closes
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2012	·	4.21	4.27	4.50	4.44	4.62	4.87	5.10	5.11	5.19	5.14	5.19
2013	5.22	5.13	5.19	5.41	5.82	5.78	6.18	5.95	5.96	5.92	5.85	5.90
2014	6.18	6.24	6.17	6.28	6.04	6.29	6.89	6.89	7.58	7.33	7.92	7.54
2015	7.57	7.97	8.70	8.83	9.34	8.95	9.29	8.59	8.35	8.38	6.30	6.26
2016	6.09	6.09	6.06	6.00	6.00	5.78	6.21	5.60	5.64	5.50	5.20	5.10
2017	4.96	5.05	5.04	4.93	4.78	4.53	4.72	4.24	4.36	4.37	4.17	4.00
2018	4.22	3.98	3.76	3.89	3.72	4.05	4.03	4.23	4.46	4.06	3.97	3.71
2019	3.76	3.74	3.89	3.98	3.64	3.45	3.43	3.19	3.15	2.92	3.10	3.14
2020	3.19	3.14	2.66	3.51	3.56	3.83	4.61	4.92	4.79	4.79	4.78	5.14
2021	5.36	5.21	4.98	5.43	5.75	5.81	5.95	5.26	5.28	5.17	4.92	4.79
2022	4.94	4.76	4.78	4.90	4.53	4.36	4.48	4.46	4.20	4.47	4.46	4.38
2023	4.33	4.17	4.02	4.29	4.29	4.48	4.80	5.15	5.02	4.11	4.23	4.42
2024	4.73	5.11	5.13	5.21	5.22	5.36	5.65	5.94	5.99	5.62	5.37	5.47
2025	5.39	5.15	5.06	5.18	5.27	5.32	5.25	4.82	4.73	4.80	4.89	4.92
2026	4.84	4.88	4.94	4.89	5.35	5.18	5.18	5.07	5.01	·	·	·

cheapestdearest

Nifty Pharma dividend yield, month by monthgreen is a HIGH yield, which is the cheap end

above +1 SD 0.84median 0.65below −1 SD 0.49

Dividend yield by month, 2012 to 2026, as the median of each month’s daily closes
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2012	·	1.27	1.26	1.19	1.21	1.21	1.15	0.84	0.82	0.79	0.79	0.78
2013	0.78	0.79	0.78	0.77	0.71	0.72	0.67	0.69	0.68	0.66	0.67	0.67
2014	0.66	0.65	0.66	0.65	0.64	0.60	0.55	0.67	0.64	0.66	0.58	0.60
2015	0.59	0.56	0.52	0.51	0.48	0.50	0.47	0.41	0.42	0.41	0.52	0.52
2016	0.54	0.54	0.54	0.55	0.55	0.57	0.52	0.52	0.43	0.44	0.47	0.48
2017	0.49	0.48	0.48	0.49	0.51	0.54	0.52	0.57	0.56	0.47	0.42	0.42
2018	0.40	0.43	0.60	0.52	0.55	0.50	0.52	0.50	0.48	0.52	0.65	0.65
2019	0.64	0.64	0.62	0.60	0.66	0.70	0.70	0.76	0.66	0.70	0.66	0.65
2020	0.64	0.66	0.78	0.59	0.58	0.54	0.49	0.47	0.77	0.79	0.80	0.74
2021	0.71	0.73	0.76	0.44	0.42	0.42	0.43	0.54	0.63	0.60	0.63	0.64
2022	0.62	0.69	0.69	0.67	0.73	0.81	0.79	0.81	0.82	1.00	1.00	1.01
2023	1.02	1.06	1.13	0.96	1.03	0.94	0.92	0.90	0.86	0.86	0.84	0.81
2024	0.76	0.71	0.72	0.69	0.65	0.62	0.60	0.60	0.59	0.58	0.61	0.60
2025	0.61	0.68	0.67	0.66	0.65	0.64	0.79	0.72	0.71	0.69	0.68	0.68
2026	0.69	0.67	0.69	0.70	0.64	0.75	0.60	0.53	0.53	·	·	·

cheapestdearest

Frequently asked questions

What is the Nifty Pharma P/E ratio today?

The Nifty Pharma closed at a price-to-earnings ratio of 41.08 on 11 September 2026. NSE publishes it once a day after the close, on a consolidated trailing-twelve-month basis, so it moves on the index and on quarterly earnings revisions — there is no intraday figure.

Is the Nifty Pharma overvalued right now?

Against its own history it is slightly expensive: a P/E of 41.08 is the 62nd percentile of 3,579 daily closes, with a ten-year median of 37.34. That describes where this index has traded, not where it should — a market can stay expensive for years, and this is not a signal to act on.

What is a good P/E ratio for the Nifty Pharma?

There is no single good number, but there is a measured middle: 30.95 to 51.46 is the middle 80% of 3,579 daily closes, and the median sits at 37.34. Below 30.95 is the cheapest tenth of this index's own history and above 51.46 the dearest tenth. Compare it to the index's own past rather than to another market's — earnings mix and growth differ, so an Indian P/E and a US one are not the same quantity.

What is the Nifty Pharma P/B ratio?

The Nifty Pharma price-to-book ratio is 4.99 as of 11 September 2026, against a ten-year median of 5.00. P/B compares the index to the book value of its constituents' assets, which makes it the steadier of the two — book value does not swing on one quarter's earnings the way a P/E denominator can.

What is the Nifty Pharma dividend yield?

The Nifty Pharma dividend yield is 0.54% as of 11 September 2026, against a ten-year median of 0.65%. It reads backwards from the other two: a HIGH yield is the cheap end, because the same dividends are being bought for a lower price.

How often does this page update, and where do the numbers come from?

From NSE's own daily index file, which carries P/E, P/B and dividend yield for every index it prices — 142 of them have a meaningful P/E today. It is published once after each close and picked up by the hourly refresh, so the figures here are the last published close, never a live quote.

Nearby indices

Nifty Non-Cyclical Consumer Nifty Oil & Gas Nifty PSE Nifty PSU Bank Nifty Private Bank Nifty REITs & InvITs Nifty Realty Nifty Rural

How to read these numbers

How to read an index P/E ratio

Consolidated trailing-twelve-month, free-float weighted, one value a day — and why the absolute number tells you almost nothing on its own.

Is the market expensive?

Valuation predicts ten-year returns and not next year’s. What that gap means, and when a reading should change anything.

Index funds Screen funds